Trexquant Investment’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-113,849
| Closed | -$1.78M | – | 1763 |
|
|
2024
Q3 | $1.78M | Sell |
113,849
-72,087
| -39% | -$1.13M | 0.02% | 852 |
|
|
2024
Q2 | $3.19M | Sell |
185,936
-92,402
| -33% | -$1.58M | 0.05% | 556 |
|
|
2024
Q1 | $4.35M | Buy |
278,338
+52,018
| +23% | +$813K | 0.09% | 354 |
|
|
2023
Q4 | $3.38M | Buy |
226,320
+159,755
| +240% | +$2.39M | 0.08% | 379 |
|
|
2023
Q3 | $1.08M | Buy |
+66,565
| New | +$1.08M | 0.03% | 725 |
|
|
2023
Q2 | – | Sell |
-3,986
| Closed | -$240K | – | 1685 |
|
|
2023
Q1 | $240K | Sell |
3,986
-272
| -6% | -$16.4K | 0.01% | 1270 |
|
|
2022
Q4 | $312K | Buy |
+4,258
| New | +$312K | 0.01% | 1087 |
|
|
2022
Q2 | – | Sell |
-6,840
| Closed | -$567K | – | 1751 |
|
|
2022
Q1 | $567K | Sell |
6,840
-23,011
| -77% | -$1.91M | 0.03% | 711 |
|
|
2021
Q4 | $2.24M | Buy |
29,851
+16,763
| +128% | +$1.26M | 0.14% | 184 |
|
|
2021
Q3 | $1.52M | Buy |
+13,088
| New | +$1.52M | 0.12% | 237 |
|
|
2021
Q2 | – | Sell |
-13,683
| Closed | -$1.81M | – | 1373 |
|
|
2021
Q1 | $1.81M | Buy |
+13,683
| New | +$1.81M | 0.17% | 163 |
|
|
2020
Q4 | – | Sell |
-15,147
| Closed | -$1.69M | – | 1355 |
|
|
2020
Q3 | $1.69M | Sell |
15,147
-5,905
| -28% | -$657K | 0.11% | 263 |
|
|
2020
Q2 | $1.25M | Buy |
21,052
+9,554
| +83% | +$566K | 0.09% | 331 |
|
|
2020
Q1 | $774K | Buy |
+11,498
| New | +$774K | 0.06% | 497 |
|
|
2019
Q4 | – | Sell |
-24,067
| Closed | -$1.8M | – | 1203 |
|
|
2019
Q3 | $1.8M | Buy |
+24,067
| New | +$1.8M | 0.16% | 183 |
|
|
2019
Q2 | – | Sell |
-32,438
| Closed | -$1.56M | – | 1024 |
|
|
2019
Q1 | $1.56M | Buy |
32,438
+25,310
| +355% | +$1.22M | 0.11% | 271 |
|
|
2018
Q4 | $239K | Buy |
+7,128
| New | +$239K | 0.01% | 855 |
|
|
2018
Q1 | – | Sell |
-25,648
| Closed | -$518K | – | 1287 |
|
|
2017
Q4 | $518K | Buy |
25,648
+14,958
| +140% | +$302K | 0.06% | 497 |
|
|
2017
Q3 | $212K | Buy |
+10,690
| New | +$212K | 0.05% | 610 |
|